ResMed(NYSE: RMD), amedical device company focused on sleep apnea and chronic obstructive pulmonary disease, reported its first-quarter results after the market closed on Thursday, April 27. While ...

If you are wondering whether ResMed is still attractive after its strong run, or if the market has already priced in the upside, this article will help you cut through the noise and focus on what the ...

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has ...

ResMed has delivered a strong set of quarterly numbers and says Ozempic-style drugs will be a boon for the business, debunking the initial narrative which clobbered its shares. Chief executive Mick ...

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...

Don't miss out on the headlines from Business. Followed categories will be added to My News. Chief executive Mick Farrell told The Australian on Friday that it was disheartening this time last year to ...